納斯達克上市公司 Basel Medical Group（BMGL）宣布，現正就一項價值 10 億美元的比特幣收購進行排他性談判，計劃透過與加密領域機構投資者及高淨值人士合作，以股權置換方式完成交易。該交易預計將在本季度內敲定，惟仍需滿足監管審批等相關條件。

Basel Medical Group (BMGL), a Nasdaq-listed company, announced that it is conducting exclusive negotiations for a $1 billion Bitcoin acquisition. The transaction is planned to be completed through equity swaps in collaboration with institutional investors and high-net-worth individuals in the cryptocurrency sector. The deal is expected to be finalized within this quarter, subject to regulatory approvals and other relevant conditions.